Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2005
08/04/2005US20050169991 Sustained release torsemide dosage forms
08/04/2005US20050169990 dry mixing oxycodon (opioids) with trimethylammoniumethyl methacrylate chloride, forming tablet by granulation and compression, curing the dosage form; superior to those of uncured tablets
08/04/2005US20050169989 Generally linear effervescent oral fentanyl dosage form and methods of administering
08/04/2005US20050169988 High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
08/04/2005US20050169986 Fast disintegrating tablets
08/04/2005US20050169985 mini-tablets with a core of venlafaxine hydrochloride,microcrystalline cellulose and polyvinylpyrrolidone, and a coating of a water soluble polymer and a water insoluble polymer, said minitablets filled in hard gelatin capsule; once daily dosage form
08/04/2005US20050169984 Preservation stability of drugs such as the penem antibiotic faropenem or faropenem daloxate by filling the capsule with an inorganic substance such as magnesium aluminometasilicate
08/04/2005US20050169983 Chewable soft capsule
08/04/2005US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability
08/04/2005US20050169981 Lactose monohydrate as diluent; tablets or capsules; stability is superior than either anhydrous lactose or starch as diluent
08/04/2005US20050169980 Liposomal composition composed of pre-formed liposomes having entrapped therapeutic agent and plurality of targeting conjugates composed of lipid, hydrophilic polymer and targeting ligand; target-cell sensitized liposome composition formed by incubating liposomal composition with selected conjugate
08/04/2005US20050169979 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
08/04/2005US20050169978 Wet-micro grinding
08/04/2005US20050169977 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
08/04/2005US20050169976 Insulin administration apparatus
08/04/2005US20050169973 Enables cooling massage or hot massage around eyes concurrently with aromatherapy; two porous synthetic resin sheets having openings for the eyes and peripheries being heat-fused to form a space therein that holds a thermal storage medium and an essential oil
08/04/2005US20050169972 Product for orally administering a substance
08/04/2005US20050169971 Pellet or tablet attractive to livestock masking a drug such as benazepril; animal feed substrate, intimately mixed with coated particles of a carrier material and an active ingredient casing that is coated by a masking protective layer
08/04/2005US20050169966 Growth promoting pharmaceutical implant
08/04/2005US20050169961 Implantable sensors and implantable pumps and anti-scarring agents
08/04/2005US20050169960 Implantable sensors and implantable pumps and anti-scarring agents
08/04/2005US20050169952 Active agent delivery device
08/04/2005US20050169895 Inhibiting proliferation with a matrix of alginate polymers and Strontium coated onto a medical, implantable device: a stent, a cardiac pacemaker, a catheter, a implantable prosthetic, a surgical screw, a surgical wire, a tissue bulking implant
08/04/2005US20050169886 Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds
08/04/2005US20050169882 Multi-functional polymeric materials and their uses
08/04/2005US20050169848 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
08/04/2005US20050169847 Process for the treatment of particles for use in pharmaceutical formulations
08/04/2005US20050167651 Controlled alignment catalytically grown nanostructures
08/04/2005DE20221244U1 Self-adhesive polymer matrix, e.g. useful in plasters, strips, wound coverings or bandages, comprises water-gelling polymer, water, seaweed extract and a mono- or polyhydric alcohol
08/04/2005DE20221243U1 Self-adhesive polymer matrix, e.g. useful in plasters, strips, wound coverings or bandages, comprises water-gelling polymer, water, seaweed extract and a mono- or polyhydric alcohol
08/04/2005DE20221242U1 Self-adhesive polymer matrix, e.g. useful in plasters, strips, wound coverings or bandages, comprises water-gelling polymer, water, seaweed extract and a mono- or polyhydric alcohol
08/04/2005DE20221241U1 Self-adhesive polymer matrix, e.g. useful in plasters, strips, wound coverings or bandages, comprises water-gelling polymer, water, seaweed extract and a mono- or polyhydric alcohol
08/04/2005DE102004001187A1 Verfahren zur Herstellung von Keto-L-gulonsäuresprühgranulaten A process for preparing keto-L-gulonsäuresprühgranulaten
08/04/2005CA2554588A1 Method of preparing low-crystallinity oltipraz or amorphous oltipraz
08/04/2005CA2554075A1 Method of protecting sensitive molecules from a photopolymerizing environment
08/04/2005CA2553967A1 Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them
08/04/2005CA2553714A1 Support accumulating in injured part in vascular channel
08/04/2005CA2553426A1 Liposome composition for delivery of therapeutic agents
08/04/2005CA2553254A1 Long-term delivery formulations and methods of use thereof
08/04/2005CA2553169A1 Solid dosage form
08/04/2005CA2552988A1 Mitratapide oral solution
08/04/2005CA2552757A1 Methods of using cgrp for cardiovascular and renal indications
08/04/2005CA2552611A1 Microemulsions for pharmaceutical compositions
08/04/2005CA2552595A1 Directly compressible pharmaceutical composition for the oral admimistration of cci-779
08/04/2005CA2552328A1 Non-animal origin stabilizers and processes for producing the same
08/04/2005CA2551807A1 Lipid-based dispersions useful for drug delivery
08/04/2005CA2495839A1 Anti-photoaging cosmeceutical composition
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559725A1 Antigen recognizing antibody
08/03/2005EP1559439A1 Drug release stent coating process
08/03/2005EP1559438A1 Hemostatic compositions and devices
08/03/2005EP1559433A1 Stabilized composition
08/03/2005EP1559431A1 Pharmaceutical composition for thrombin peptide derivatives
08/03/2005EP1559426A1 Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
08/03/2005EP1559425A1 Peroral preparation for prevention of or treatment for atopic dermatitis
08/03/2005EP1559419A1 Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
08/03/2005EP1559418A1 Compositions for treating pain of the mucous membrane
08/03/2005EP1559395A2 Microemulsion
08/03/2005EP1558935A2 Controlled-release compositions
08/03/2005EP1558562A1 Cationic cardiolipin analogs and use thereof
08/03/2005EP1558330A2 Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system
08/03/2005EP1558288A1 Gastric acid secretion inhibiting composition
08/03/2005EP1558279A1 Oral formulation of botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease
08/03/2005EP1558273A2 Treatment and prevention of pulmonary conditions
08/03/2005EP1558272A1 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
08/03/2005EP1558270A1 Dietary supplement comprising parthenolide
08/03/2005EP1558269A2 Botulinum toxin formulations for oral administration
08/03/2005EP1558264A2 Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid and the retina; and related methods for treatment and/or prevention of retinal diseases
08/03/2005EP1558262A1 Water-soluble meloxicam granulates
08/03/2005EP1558257A1 Dosage form that is safeguarded from abuse
08/03/2005EP1558254A2 A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye, compositions resulting therefrom
08/03/2005EP1558241A2 Pharmaceutical compositions and methods of using taxane derivatives
08/03/2005EP1558228A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails
08/03/2005EP1558227A1 Injectable 2,6-diisopropylphenol-containing anesthetic composition and methods
08/03/2005EP1558226A2 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
08/03/2005EP1558225A1 Adhesive composition for dermal patch and production process thereof
08/03/2005EP1558224A1 Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
08/03/2005EP1558223A2 Dosage form having an inner core and at least two coating layers
08/03/2005EP1558222A2 Pharmaceutical compositions containing venlafaxine
08/03/2005EP1558221A1 Dosage form that is safeguarded from abuse
08/03/2005EP1558220A1 Oral compositions for treatment of diseases
08/03/2005EP1558219A1 Pharmaceutical formulation of olanzapine
08/03/2005EP1558218A1 Gabapentin tablets and methods for their preparation
08/03/2005EP1558217A1 Wet granulation process
08/03/2005EP1558216A2 Cross-linked polymer matrices, and methods of making and using same
08/03/2005EP1558215A1 Sterile gelling agents
08/03/2005EP1558214A1 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same
08/03/2005EP1558213A2 Mucoadhesive tetracycline formulations
08/03/2005EP1558212A1 Pharmaceutical and cosmetic formulations
08/03/2005EP1558211A2 Oral extended release tablets and methods of making and using the same
08/03/2005EP1558210A2 Cartilage enhancing food supplements with sucralose and methods of preparing the same
08/03/2005EP1558209A1 Transmucosal pharmaceutical administration form
08/03/2005EP1558206A1 Formulations for topical delivery of bioactive substances and methods for their use
08/03/2005EP1558094A1 Use of branched malto-dextrins as granulation binders
08/03/2005EP1359976A4 Fluid retention assembly for an iontophoretic delivery
08/03/2005EP1283708B1 Use of biguanide derivatives for making a medicine having a wound healing effect
08/03/2005EP1278795B1 Azeotrope-like compositions of pentafluoropropane and water
08/03/2005EP1227806B1 Pharmaceutical formulation containing tolterodine and its use
08/03/2005EP1207861B1 Treatment of fungal infections utilizing a fungal growth medium
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
1 ... 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 ... 2991